A 67-year-old African American male with a past medical history of hypertension and seizure disorder presented with a week history of abdominal pain, poor appetite, and nausea. The patient had also noticed bilateral leg swelling for the last several weeks that was worse toward the end of the day and resolved upon propping up his legs. He has a history of heavy alcohol use as well as 20 pack-year history of smoking.
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At presentation, he was afebrile with stable vital signs. Physical examination revealed a thin appearing male in no apparent distress. Scleral icterus was present. Lung and heart examination was within normal limits. Abdominal examination revealed a vague right upper quadrant mass with no tenderness or guarding/rigidity. A complete blood count was within normal limits. Comprehensive metabolic panel was notable for mildly elevated bilirubin at 1.1 mg/dl, elevated aspartate aminotransferase at 220 IU/ml, alanine aminotransferase at 34 IU/ml, and alkaline phosphatase at 138 IU/ml.
A computed tomography of the abdomen showed a large invasive, poorly marginated, irregularly enhancing, 14-cm mass occupying the right lobe of the liver with tumoral invasion of the inferior vena cava and right atrium. A subsequent magnetic resonance imaging of the abdomen showed a 15-cm right liver mass with features suggestive of hepatocellular carcinoma. Alfa-fetoprotein was mildly elevated at 10.1 ng/ml. Further evaluation with a transthoracic echocardiography revealed a right atrial mass 2Á3 cm in diameter along with Inferior Venacava (IVC) dilation and obstruction ( Fig. 1 and Video 1) .
The patient was deemed to be a nonsurgical candidate based on the vascular spread of his malignancy. He was followed up in the hematologyÁoncology clinic with an intention of starting systemic chemotherapy with sorafenib, given his excellent performance status. 
